Table 4 Product attributes and their levels confirm which tables remain in the manuscript.
Attribute | Description of levels | Attribute type | |||
|---|---|---|---|---|---|
Oral | Injection | Vaginal ring | Implant | ||
Frequency | Weekly | Every 2 Months | Monthly | Every 6 Months | Continuous |
Monthly | Every 6 months | Every 3 months | Every 12 months | ||
Effectiveness | 70–80% | 85–90% | 50–70% | 80–90% | Continuous |
80–90% | 90–95% | 70–90% | 90–95% | ||
Prevents pregnancy | No | No | No | No | Categorical |
Yes | Yes | Yes | Yes | ||
Prevents STIs | No | No | No | No | Categorical |
Yes | Yes | Yes | Yes | ||
Product access location | Public Health Facility (HF) | Public HF | Public HF | Public HF | Categorical |
Private HF | Private HF | Private HF | Private HF | ||
Public and private HFs | Public and private HFs | Public and private HFs | Public and private HFs | ||
Private Pharmacies | |||||
Cost | KES 100 | KES 500 | KES 500 | KES 500 | Continuous |
KES 300 | KES 1,000 | KES 1,000 | KES 1,000 | ||
KES 500 | KES 1,500 | KES 1,500 | KES 1,500 | ||
